BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 4.222
EU - Europa 2.313
AS - Asia 1.078
SA - Sud America 175
AF - Africa 17
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 7.811
Nazione #
US - Stati Uniti d'America 4.190
GB - Regno Unito 890
IT - Italia 376
SG - Singapore 299
CN - Cina 292
SE - Svezia 253
HK - Hong Kong 246
DE - Germania 178
IE - Irlanda 170
BR - Brasile 150
RU - Federazione Russa 90
UA - Ucraina 81
FR - Francia 60
FI - Finlandia 57
TR - Turchia 44
ID - Indonesia 41
BG - Bulgaria 35
IN - India 33
KR - Corea 28
BE - Belgio 24
NL - Olanda 22
CA - Canada 21
VN - Vietnam 19
ES - Italia 9
GR - Grecia 9
JP - Giappone 9
MK - Macedonia 9
MY - Malesia 9
PH - Filippine 9
LT - Lituania 8
AT - Austria 7
ZA - Sudafrica 7
AR - Argentina 6
CH - Svizzera 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
MX - Messico 5
PL - Polonia 5
UZ - Uzbekistan 5
VE - Venezuela 5
BD - Bangladesh 4
IR - Iran 4
NP - Nepal 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
BH - Bahrain 3
BO - Bolivia 3
CL - Cile 3
CO - Colombia 3
CY - Cipro 3
EC - Ecuador 3
IL - Israele 3
JO - Giordania 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
DK - Danimarca 2
EE - Estonia 2
ET - Etiopia 2
IQ - Iraq 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MA - Marocco 2
OM - Oman 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GP - Guadalupe 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
TH - Thailandia 1
TM - Turkmenistan 1
ZM - Zambia 1
Totale 7.811
Città #
Southend 661
Fairfield 582
Santa Clara 465
Woodbridge 327
Chandler 311
Ashburn 304
Hong Kong 244
Houston 225
Seattle 213
Ann Arbor 192
Singapore 180
Dublin 169
Wilmington 169
Dearborn 161
Cambridge 160
Nyköping 147
Jacksonville 125
London 103
Beijing 91
Modena 73
New York 52
San Diego 52
Jakarta 37
Princeton 35
Sofia 34
Shanghai 33
Eugene 32
Hefei 32
Moscow 32
Council Bluffs 31
Helsinki 30
Redwood City 28
Bologna 27
Milan 25
Izmir 22
Brussels 20
Munich 20
Bremen 19
Boardman 18
Fremont 18
The Dalles 18
Rome 16
San Francisco 15
Seoul 14
Turin 14
Dong Ket 13
Los Angeles 13
Norwalk 13
São Paulo 13
Chicago 11
Reggio Emilia 10
Ottawa 9
Paris 9
Seongnam 9
Frankfurt am Main 8
Phoenix 7
Falls Church 6
Istanbul 6
Nanjing 6
Brasília 5
Brooklyn 5
Carpi 5
Changchun 5
Kilburn 5
Monza 5
Roggiano Gravina 5
Toronto 5
Turku 5
Bangalore 4
Chiswick 4
Curitiba 4
Dallas 4
Falkenstein 4
Fulham 4
Grafing 4
Guangzhou 4
Hounslow 4
Kunming 4
Monmouth Junction 4
Mountain View 4
Nanchang 4
North Bergen 4
Nuremberg 4
Parma 4
Rio de Janeiro 4
San Jose 4
San Mateo 4
Skopje 4
Tashkent 4
Tokyo 4
Warsaw 4
Zhengzhou 4
Alzate Brianza 3
Amsterdam 3
Athens 3
Bagnacavallo 3
Barcelona 3
Chios 3
Columbus 3
Comun Nuovo 3
Totale 5.874
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 388
Non-steroid agents for idiopathic pulmonary fibrosis 344
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 339
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 308
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 288
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 269
Short-term and long-term effects of tibolone in postmenopausal women 259
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 250
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 248
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 238
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 235
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 233
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 225
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 225
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 221
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 219
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 216
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 209
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 208
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 202
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 200
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 200
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 200
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 192
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 190
Trastuzumab containing regimens for early breast cancer. 189
Trastuzumab-containing regimens for metastatic breast cancer 188
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 178
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 174
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 171
Short and long term effects of tibolone in postmenopausal women 165
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 161
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 152
Erlotinib for advanced pancreatic cancer 116
Outpatient parents' views on shared-decision-making at an Italian children's hospital 94
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 74
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 71
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 51
Totale 7.890
Categoria #
all - tutte 31.338
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.338


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 0 0 0 0 0 47
2020/20211.171 103 48 106 85 131 86 88 129 79 157 115 44
2021/2022819 46 47 97 43 27 49 33 57 91 82 157 90
2022/20231.033 95 123 72 92 94 100 26 94 261 13 18 45
2023/2024622 21 28 46 53 103 59 80 63 23 39 43 64
2024/20251.818 57 25 38 110 371 321 148 117 170 76 179 206
Totale 7.890